Medical cannabis laws by state

427 bills on medical cannabis in 50 jurisdictions, 68 of them enacted in 2025 and 2026. The laws come first, with what each requires, then the bills that moved most recently.

  • 68 laws enacted in 2025 and 2026, in 31 states. Most: Oklahoma (11), Utah (6), District of Columbia (5).
  • 427 bills in 50 jurisdictions, 1 of them in Congress. Latest action 23 October 2026.

Updated 2 November 2026LawsRecent billsBy state

Enacted in 2025 and 2026

68 laws, by state. Laws enacted before 2025 are not listed.

Arizona

  • Enacted

    SB 1105: medical marijuana dispensaries; location

    Nonprofit medical marijuana dispensaries and marijuana establishments must locate at least five hundred feet from public or private schools, child care facilities, or facilities providing preschool programs. Localities may enact zoning regulations limiting marijuana establishments to specified areas but cannot make operations unduly burdensome or more restrictive than rules applying to nonprofit medical marijuana dispensaries.

Arkansas

  • Enacted

    SB 305: To require certain testing of processed marijuana products sold as medical marijuana.

    Requires testing of processed marijuana products sold as medical marijuana for concentrations of tetrahydrocannabinol and cannabidiol, while clarifying the section does not authorize or prohibit specific products including prerolls, blunts, or other ready-made inhalables.

  • Enacted

    HB 1452: Clarifying the law on the use of medical marijuana in certain places; and to prohibit the possession of an unsealed container of certain forms of medical marijuana in a motor vehicle.

    A person must not knowingly use medical marijuana through vapor inhalation in specified prohibited places including school buses, daycare centers, schools, universities, correctional facilities, public transportation, and military property. A person must not knowingly smoke medical marijuana in places where tobacco smoking is prohibited, in the presence of persons under fourteen years of age, inside motor vehicles, in the presence of pregnant women, or where it would cause unauthorized persons to be under the influence. A person must not possess uncontained medical marijuana in a form readily usable through smoking within readily accessible areas of motor vehicles on public highways.

Colorado

  • Enacted

    SB 7: Medical Marijuana Use in Health Facilities

    Health facilities may allow terminally ill patients registered with the medical marijuana program to use medical marijuana in non-smoking or non-vaping forms consistent with physician recommendations. Health facilities must require proof of valid registry identification, document usage in medical records, develop written guidelines for possession and storage, and reasonably restrict use to ensure safety and compliance with state law.

  • Enacted

    HB 25-1209: Marijuana Regulation Streamline

  • Enacted

    HB 25-1296: Tax Expenditure Adjustment

    Employers must deduct and withhold income tax from employee compensation including wages and other compensation, using percentages or withholding tables prescribed by the executive director to approximate Colorado income tax due. The executive director may require withholding on compensation other than wages. Employers must provide employees annual statements of compensation and tax withheld.

Delaware

  • Enacted

    SB 226: An act to amend title 16 of the delaware code relating to medical marijuana.

    A patient or the patient's caregiver must notify the patient's attending physician of the patient's use of medical marijuana. The act limits the scope of medical marijuana facilities to general hospitals licensed pursuant to paragraph 1001(b)(1) of Delaware Code Title 16.

District of Columbia

  • Enacted

    B 26-0759: Medical Cannabis Licensing and Unlicensed Establishment Enforcement Clarification Emergency Amendment Act of 2026

    Licensed establishments and unlicensed establishments must not sell, exchange, or deliver Schedule I substances or products containing Schedule I substances. Conditional license holders must not engage in purchasing, possessing, cultivating, manufacturing, or selling medical cannabis, cannabis products, or Schedule I substances. Retailers and internet retailers must not locate within 400 feet of preschools, primary or secondary schools, or recreation centers, except as specified.

  • Enacted

    PR 26-0779: Medical Cannabis Licensing and Unlicensed Establishment Enforcement Clarification Emergency Declaration Resolution of 2026

    This resolution declares an emergency to extend medical cannabis conditional licenses for an additional year and clarify enforcement authority against unlicensed establishments selling Schedule I substances, pending permanent legislation in the fall.

  • Enacted

    PR 26-0336: Streatery Program Endorsement Extension and Medical Cannabis Clarification Congressional Review Emergency Declaration Resolution of 2025

    Declares an emergency to continue the Streatery Program allowing licensed establishments to sell beer, wine, or spirits on expanded outdoor space through December 31, 2025, and to clarify geographic requirements for medical cannabis licensees.

  • Enacted

    B 26-0299: Streatery Program Endorsement Extension and Medical Cannabis Clarification Emergency Amendment of 2025

    Licensees holding on-premises retailer licenses class C/T, D/T, C/N, or D/N, or manufacturer licensees class B, must pay the Streatery Program endorsement fee for 2025 by September 30, 2025. All other licensees must pay annually with the 2025 fee due by April 1, 2025. Retailer and internet retailer license holders must not locate within 400 feet of a preschool, primary or secondary school, or recreation center, except as specified for certain applicants and unlicensed establishment license holders.

  • Enacted

    PR 26-0256: Streatery Program Endorsement Extension and Medical Cannabis Clarification Emergency Declaration Resolution of 2025

    Declares an emergency to allow the Council to pass the Streatery Program Endorsement Extension and Medical Cannabis Clarification Emergency Amendment Act of 2025 after a single reading, enabling continuation of the Streatery Program through December 31, 2025.

Florida

  • Enacted

    HB 1299: Department of Health

    Medical marijuana treatment centers must notify the Department of Health by email within 24 hours of actual or attempted theft, diversion, or loss of marijuana and report attempted thefts to law enforcement within the same timeframe. The act also revises licensure requirements for various health professions and establishes a physical therapy compact among member states.

Georgia

  • Enacted

    SB 220: "Putting Georgia's Patients First Act"; enact

  • Enacted

    SB 395: Department of Public Health; eligible for the Low THC Oil Patient Registry; require a physician to submit certain information to the Georgia Composite Medical Board

    Physicians must submit annual reports to the Georgia Composite Medical Board containing information including dosages recommended, patient clinical responses, tetrahydrocannabinol levels, compliance, treatment responses, side effects, and drug interactions. The Department of Public Health must disclose Low THC Oil Patient Registry information to the board for investigatory, compliance, or disciplinary purposes.

Hawaii

  • Enacted

    HB 302: Relating to cannabis.

    Physicians and advanced practice registered nurses may establish bona fide relationships via telehealth without initial in-person consultation to certify patients for medical cannabis. Persons must not operate dispensaries without a license or operate search platforms, web hosting services, or social media platforms advertising unlicensed cannabis sales. Certifying providers' fees shall not exceed three times the department of health's registration certificate fee.

  • Enacted

    SB 1429: Relating to medical cannabis.

    Qualifying patients may obtain medical cannabis from licensed dispensaries, by cultivating cannabis not exceeding an adequate supply, or from a primary caregiver who cultivates cannabis not exceeding an adequate supply. Primary caregivers shall register with the department of health and be responsible for not more than five qualifying patients at any given time, with exceptions for parents or guardians of multiple minor qualifying patients.

Iowa

  • Enacted

    HF 990: A bill for an act relating to the issuance of medical cannabidiol registration cards and licensure of medical cannabidiol dispensaries.

Louisiana

  • Enacted

    SB 270: HEALTH CARE: Provides for access to medical marijuana for terminally ill patients in a healthcare facility. (8/1/26)

    Healthcare facilities must permit patient use of medical marijuana for terminally ill patients with current medical marijuana recommendations. Patients or primary caregivers must acquire, retrieve, administer, and remove medical marijuana. Healthcare facility staff including physicians, nurses, and pharmacists must not administer, store, retrieve, or assist with medical marijuana. Facilities must develop written guidelines and train staff on these policies.

  • Enacted

    HB 657: MEDICAL MARIJUANA: Provides relative to fees collected by the Louisiana Department of Health related to the sale of therapeutic marijuana (EN +$225,000 SG RV See Note)

Maine

  • Enacted

    LD 1609: An Act To Prevent The Participation Of Individuals And Companies Linked To Federally Recognized Criminal Organizations In The Medical And Adult Use Cannabis Programs

    The department must conduct criminal history record checks for applicants for registry identification cards and registration certificates, and for registrants and registrant agents every 2 years. The department may not issue a registry identification card or registration certificate to any applicant or officer or director convicted of a disqualifying drug offense.

  • Enacted

    LD 1840: An Act To Amend The Maine Medical Use Of Cannabis Act

    The Department of Administrative and Financial Services, Office of Cannabis Policy may not require registrants to make attestations on forms or documents regarding authorized conduct except when explicitly authorized or directed under the Maine Medical Use of Cannabis Act or its rules. Caregivers are authorized to sell, offer to sell, furnish or transport cannabis plants or harvested cannabis on owned, leased or rented property, at trade shows, or through delivery to qualifying patients or registrants. The office must make registration and renewal forms available on its website as portable document files and in paper form by expeditiously providing them.

  • Enacted

    LD 1897: An Act Regarding Sun-Grown Cultivation In The Medical Use And Adult Use Cannabis Industries

    Sun-grown cultivators registering for medical use cannabis cultivation may cultivate up to 150 mature cannabis plants annually or up to 2,500 square feet of mature plant canopy annually. Caregivers must keep mature and immature plants in separate cultivation areas and disclose all cultivation area locations to the department. Caregivers may maintain no more than 2 cultivation areas.

Maryland

  • Enacted

    SB 439: Employment Discrimination - Fire and Rescue Public Safety Employees - Use of Medical Cannabis

    An employer may not discipline, discharge, or discriminate against a fire and rescue public safety employee based on possession of a valid written certification for medical cannabis or testing positive for cannabis components while holding such certification. Employers may prohibit employees from performing duties while impaired by cannabis or using cannabis while on duty.

    Took effect 1 October 2026

Massachusetts

  • Enacted

    H 5350: An Act modernizing the commonwealth’s cannabis laws

    The Massachusetts cannabis control commission must establish and maintain an online portal for anonymous complaints about suspected violations, review complaints timely, and adopt procedures to assess them. Licensees must not receive or extend credit for marijuana sales beyond 60 days except in usual business course. The commission must limit total licenses available and conduct targeted audits of ownership and control compliance within 12 months.

Minnesota

  • Enacted

    SF 4401: Omnibus Cannabis bill

    License holders must comply with cannabis business licensing, endorsement, and operational requirements. Manufacturers of edible cannabinoid products must meet testing, labeling, packaging, and potency limits. Retailers must verify age before selling edible cannabinoid products and register with the office.

  • Enacted

    SF 2370: Omnibus Cannabis Policy Bill

    The Office of Cannabis Management must register two in-state medical cannabis manufacturers and review medical and scientific literature on dosages and chemical compositions for qualifying conditions. Manufacturers must cultivate, acquire, manufacture, possess, prepare, transfer, transport, supply, or dispense medical cannabis and related supplies. Edible cannabinoid products must not exceed specified tetrahydrocannabinol limits and must meet packaging and labeling requirements.

Mississippi

  • Enacted

    SB 2729: "Mississippi Public Health Trust Fund"; establish to support public health programs funded from medical cannabis taxes.

    Establishes the Mississippi Public Health Trust Fund in the State Treasury to receive legislative appropriations, donations, and grants for public health programs. Authorizes the State Department of Health to disburse between 3% and 7% of fund assets annually with Board of Health oversight.

    Took effect 1 July 2025

  • Enacted

    SB 2748: Mississippi Medical Cannabis Act; revise provisions related to.

    Applicants for medical cannabis establishment licenses must not apply to a county or municipality for zoning or permitting actions until after receiving a license from MDOH or MDOR. Healthcare practitioners may issue written certifications via telemedicine for homebound or bedbound patients. One MMCEU equals one gram of total THC in cannabis concentrate or infused products.

    Took effect 1 July 2025

Missouri

  • Enacted

    HB 2641: Creates provisions relating to cannabis

    Entities licensed by the department must be the sole cultivators, producers, manufacturers, testers, transporters, and retailers of hemp-derived cannabinoid products. State agencies must not disclose statewide lists or individual information of medical marijuana cardholders to the federal government or unauthorized third parties unless required by subpoena or court order. Marijuana dispensary facilities must not create or retain consumer identifying information unless the consumer affirmatively agrees in writing.

Montana

  • Enacted

    SB 74: Generally revise marijuana laws

    Marijuana cultivators, manufacturers, and dispensaries must obtain licenses from the department of revenue and comply with cultivation, manufacturing, and sales requirements. Licensees must submit samples for testing, participate in seed-to-sale tracking, and comply with THC content limits. Property owners must provide written permission for licensed premises on rented or leased property.

Nebraska

  • Enacted

    LB 1235: Change provisions of the Nebraska Liquor Control Act and the Nebraska Medical Cannabis Regulation Act

    Businesses in consumption-only entertainment district areas must not sell or serve alcoholic liquor but may allow patrons to carry beverages sold by other entertainment district licensees. Applicants for medical cannabis registration must submit two sets of fingerprints for FBI criminal history checks. The Nebraska Medical Cannabis Commission members receive annual salaries of twelve thousand five hundred dollars.

  • Enacted

    LB 1: Eliminate an incorrect reference in provisions of the medical cannabis initiative petition language adopted by the voters

    Amends two voter-adopted medical cannabis initiative laws to correct an incorrect subdivision reference in the definition of cannabis, changing "section 2-503" to "Section 2-503(13)" of the Nebraska Hemp Farming Act in both Initiative Law 2024, No. 437 and No. 438.

Nevada

  • Enacted

    AB 365: Eliminates provisions requiring the University of Nevada, Reno, School of Medicine to establish a program relating to the medical use of cannabis. (BDR 19-758)

    Repeals provisions requiring the University of Nevada, Reno, School of Medicine to establish a program for evaluation and research of medical cannabis use for chronic or debilitating medical conditions, and removes related references from public records law.

New Jersey

  • Enacted

    A 5051: Revises certain restrictions concerning hemp, intoxicating hemp beverages, and medical cannabis.

    Sellers must not sell viable Cannabis sativa seeds exceeding 0.3 percent THC, intermediate hemp-derived products with non-naturally produced cannabinoids or exceeding 0.3 percent combined THC, final hemp-derived products exceeding 0.4 milligrams combined THC per container, or intoxicating hemp beverages through online retail or vending machines. Intoxicating hemp beverages sold must comply with container and THC limits and include certificates of analysis.

  • Enacted

    A 913: Authorizes medical cannabis for treatment of sickle cell anemia.

    Adds sickle cell anemia to the list of qualifying medical conditions for which patients may be authorized to use medical cannabis under New Jersey law.

New York

  • Enacted

    S 3294: Relating to medical use of cannabis and to the controlled substances therapeutic research act; repealer

    Practitioners must complete appropriate training as determined by the board before issuing certifications for medical cannabis. Registered organizations must validate certifications and government-issued photo identification before dispensing medical cannabis. Certified patients and designated caregivers must notify practitioners of name or address changes.

    Took effect 19 February 2026

North Dakota

  • Enacted

    SB 2294: AN ACT to create and enact a new section to chapter 19-24.1 of the North Dakota Century Code, relating to qualifying nonresident medical marijuana patients; to amend and reenact subsection 3 of section 19-24.1-01, subsection 4 of section 19-24.1-01, subsection 8 of section 19-24.1-01, subsection 26 of section 19-24.1-01, subsection 47 of section 19-24.1-01, and sections 19-24.1-03, 19-24.1-11, and 19-24.1-37 of the North Dakota Century Code, relating to allowable amounts of usable medical marijuana, medical marijuana recordkeeping, cannabinoid edible products, patient qualifications, and disclosure of information.

    The department must issue registry identification cards to qualifying patients, including seniors over fifty and nonresidents with valid out-of-state medical marijuana cards, within thirty calendar days of approving applications. Cannabinoid edible products are limited to soft or hard lozenges in geometric square shape with maximum five milligrams tetrahydrocannabinol per serving and fifty milligrams per package.

  • Enacted

    HB 1203: AN ACT to create and enact section 19-24.1-24.1 and a new subsection to section 19-24.1-36 of the North Dakota Century Code, relating to regulating edible medical marijuana products; and to amend and reenact section 19-24.1-01 of the North Dakota Century Code, relating to definitions of medical marijuana products.

    Manufacturing facilities must obtain prior department approval before manufacturing cannabinoid edible products. Dispensaries must obtain prior department approval before possessing, marketing, or selling cannabinoid edible products. The department must review and approve the form, manufacturing, packaging, labeling, and marketing of each cannabinoid edible product before approval.

  • Enacted

    SB 2293: AN ACT to amend and reenact subsections 7 and 18 of section 19-24.1-01, and subdivision c of subsection 2 of section 19-24.1-03 of the North Dakota Century Code, relating to medical marijuana container sizes, caregivers, and documentation.

    Containers holding cannabinoid concentrate for dispensing may not exceed one gram. Designated caregivers must be at least twenty-one years of age and agree to manage the well-being of registered qualifying patients regarding their medical use of marijuana. Qualifying patient applications must include the applicant's name, address, date of birth, proposed designated caregiver information, photographic identification, and a disclosure about firearm possession and federal law.

Ohio

  • Enacted

    SB 56: Revise medical and adult-use marijuana laws; levy marijuana taxes

    Consolidates marijuana regulation under a new Division of Cannabis Control in the Department of Commerce. Establishes licensing standards for hemp cultivation and processing, allows expungement of certain prior marijuana possession convictions, and revises professional licensing disqualification rules.

Oklahoma

  • Enacted

    SJR 53: Joint resolution; approving certain proposed permanent rules of the Oklahoma Medical Marijuana Authority.

    Approves specified permanent rules of the Oklahoma Medical Marijuana Authority designated as major rules under Oklahoma law. Directs the Secretary of State to distribute copies to the Governor and Oklahoma Register editor.

  • Enacted

    HB 4454: Medical marijuana; providing certain restrictions on edible products; effective date.

    Licensed medical marijuana processors must ensure edible products clearly indicate the number of servings and tetrahydrocannabinol amount per serving. Edible products must not be attractive to children, manufactured in shapes of humans or cartoons, or resemble commercially available candy.

    Took effect 1 November 2026

  • Enacted

    HB 3143: Medical marijuana; modifying dates for moratorium; providing restrictions when transferring ownership of medical marijuana business; effective date.

    Licensees intending to transfer ownership of a medical marijuana business must submit an application to the Oklahoma Medical Marijuana Authority for written approval before transfer. Licensees subject to administrative action or pending appeals must complete those proceedings before submitting a transfer application. Licensees whose licenses are annulled, revoked, or suspended must wait at least six months before applying to transfer.

    Took effect 1 August 2026

  • Enacted

    HB 3127: Medical marijuana; policy for applicants and employees; exceptions; effective date.

    Employers may not refuse to hire, discipline, discharge or penalize applicants or employees solely based on medical marijuana licensee status or positive marijuana tests, unless the applicant lacks a valid license, possesses or uses marijuana at work, or the position involves safety-sensitive duties as defined.

    Took effect 1 November 2026

  • Enacted

    SB 1039: Medical marijuana license; modifying grounds for certain denials; notice; fees. Effective date.

    The Oklahoma Medical Marijuana Authority must review medical marijuana business applications and approve, reject, or deny them within ninety business days, providing written notice with reasons. Applicants must submit complete applications with required fees and documentation. Medical marijuana business licensees must cease all possession, transfer, or sale upon license expiration.

    Took effect 1 November 2025

  • Enacted

    HB 2807: Medical marijuana; medical marijuana transporter license; providing issuance of licenses for premises under certain circumstances; directing creation of inventory manifests documenting certain information; allowing certain licensees to maintain and operate warehouses under certain conditions; effective date; emergency.

    Licensed medical marijuana transporters must use the seed-to-sale tracking system to create shipping inventory manifests documenting transport and temporary storage of medical marijuana products. Transporters may maintain and operate warehouses upon receiving annual permits for each location. Beginning June 1, 2025, processors and growers must sell flower-based products to dispensaries only in pre-packaged form weighing one-half gram to three ounces.

  • Enacted

    HB 2837: Medical marijuana; requiring medical marijuana business employees to submit proof of completion of education training; effective date.

    Beginning January 1, 2026, all employees of a licensed medical marijuana business must annually complete an educational training course provided by or approved by the Oklahoma Medical Marijuana Authority and submit proof of completion to receive an employee credential. The Authority shall provide a list of topics to be included in training.

  • Enacted

    SB 518: Medical marijuana packaging; requiring certain warnings on labels. Effective date.

    Medical marijuana businesses must package and label medical marijuana products to minimize appeal to children, avoid false or misleading statements, and include specific warnings: "For use by licensed medical marijuana patients only", "Keep out of reach of children", warnings about driving and pregnancy, and a statement that the product has been tested for contaminants. Dispensaries must return non-compliant products or dispose of them.

    Took effect 1 November 2025

  • Enacted

    SB 786: Crimes and punishments; increasing certain fine; prohibiting certain consumption of medical marijuana. Effective date.

    Operators and passengers must not transport or possess open intoxicating beverages or low-point beer in moving vehicles on public highways except in rear trunks or inaccessible compartments. Persons operating motor vehicles must not consume marijuana, inhale secondhand marijuana smoke, or possess open marijuana containers in passenger areas.

    Took effect 1 November 2025

  • Enacted

    SB 774: Medical marijuana licenses; modifying certain identification number; requiring certain barcode. Effective date.

    The Oklahoma Medical Marijuana Authority must make available a method to validate medical marijuana patient licenses by twelve-character identification number and PDF417 barcode on its website and through a telephone verification system. Dispensaries must verify patient or caregiver licenses using the twelve-character identifier and PDF417 barcode.

    Took effect 1 November 2025

  • Enacted

    SB 1066: Medical marijuana; requiring creation and maintenance of certain registry; providing certain requirements for listing on registry. Emergency.

    Licensed allopathic, osteopathic, and podiatric physicians must complete medical education related to medical marijuana prior to being listed on the Oklahoma Medical Marijuana Authority's registry and annually thereafter to remain listed. Beginning January 1, 2026, physicians must be registered with the Authority to provide medical marijuana recommendations. Medical marijuana businesses must implement inventory tracking systems and maintain transaction records.

Oregon

  • Enacted

    HB 4142: Relating to marijuana for medical use; and prescribing an effective date.

    Organizations or residential facilities designated as additional caregivers under ORS 475C.791 must allow patients to engage in medical use of marijuana on premises, create and maintain written policies for procurement, storage, administration and disposal of marijuana and medical cannabinoid products, and ensure direct care staff complete educational training covering cannabis pharmacology, dosing strategies, and drug interactions prior to providing care to patients using marijuana.

South Dakota

  • Enacted

    SB 90: expand the information required to be sent to the prescription drug monitoring program for each registry identification card holder.

    The department shall submit to the prescription drug monitoring program for each cardholder and nonresident cardholder the cardholder's name, physical address (except no address is required if the applicant is homeless), date of birth, and registry identification card number.

    Took effect 1 July 2026

Tennessee

  • Enacted

    SB 550: Health Care - As enacted, increases the number of members on the medical cannabis commission from nine to 10, and provides that the additional member must be a member who is a specialist in the area of substance abuse prevention and serve as a nonvoting member. - Amends TCA Title 4 and Title 68, Chapter 7.

    The speaker of the senate must appoint one member who is a specialist in the area of substance abuse prevention to the medical cannabis commission. The speaker shall select this member from a list of three names submitted by the Prevention Alliance of Tennessee, with appointment on or after July 1, 2025.

  • Enacted

    SB 299: Boards and Commissions - As enacted, changes the qualifications for membership on the medical cannabis commission to include a patient caregiver and a subject matter expert with knowledge of how cannabis is cultivated, processed, shipped, distributed, or prescribed for medical use; specifies that the recommendations made by the commission to the general assembly may include policy recommendations. - Amends TCA Title 4 and Title 68, Chapter 7.

    The governor shall appoint three members to the medical cannabis commission from each grand division, including one patient or patient caregiver, one subject matter expert with knowledge of cannabis cultivation, processing, shipping, distribution, or prescription, and one member meeting either qualification. The commission shall report findings and recommendations including policy recommendations to the general assembly.

  • Enacted

    HB 255: Sunset Laws - As enacted, extends the medical cannabis commission to June 30, 2029. - Amends TCA Title 4, Chapter 29 and Title 68, Chapter 7.

    Removes the medical cannabis commission from a sunset provision in Tennessee Code Annotated Section 4-29-246(a) and adds it to a different sunset list in Section 4-29-250(a), extending its authorization to June 30, 2029.

Texas

  • Enacted

    HB 46: Relating to the medical use of low-THC cannabis under and the administration of the Texas Compassionate-Use Program; requiring registration.

    Dispensing organizations must register directors, owners, managers, and employees with the department. License holders must begin dispensing low-THC cannabis within 24 months of licensure and maintain minimum dispensing activity. Dispensing organizations cannot operate within 1,000 feet of school premises and cannot dispense products exceeding one gram of tetrahydrocannabinols per package or medical device.

    Took effect 1 September 2025

Utah

  • Enacted

    SB 121: Medical Cannabis Program Amendments

    Cannabis production establishments and medical cannabis pharmacies must comply with amended labeling, storage, remediation, and operational requirements. Medical cannabis cardholders may transport medical cannabis as amended. The department shall contract with a nonprofit entity to provide monthly $150 vouchers to eligible medical cannabis patients enrolled in Medicaid or Medicare.

    Took effect 6 May 2026

  • Enacted

    SB 66: Medical Cannabis Pharmacy License Amendments

    The Department of Agriculture and Food shall divide the state into at least four geographic regions for locating medical cannabis pharmacies through rulemaking. The licensing board may not approve a request to change a medical cannabis pharmacy location outside the pharmacy's current region. The licensing board shall evaluate pharmacy license applicants using specified criteria including experience, safety, community connections, location suitability, cost efficiency, and strategic planning.

  • Enacted

    HB 389: Cannabis Amendments

    Industrial hemp retailer permittees must check identification of purchasers of cannabinoid products containing THC or THC analogs to ensure they are at least 21 years old. Licensees and permittees must dispose of waste and unused material from cannabinoid production in accordance with hazardous waste laws. Medical cannabis processors may produce low THC products below 0.3% THC content.

    Took effect 6 May 2026

  • Enacted

    SB 64: Medical Cannabis Amendments

    Medical cannabis pharmacies and couriers must report changes in ownership at least 45 days before the change occurs. Cannabis processing facilities must comply with limits on the number of licenses the Department of Agriculture and Food may issue. Qualified medical provider employee proxies must complete a course on health information privacy.

    Took effect 7 May 2025

  • Enacted

    HB 357: Medical Cannabis Modifications

    Certain health care providers may recommend medical cannabis without registering with the Department of Health and Human Services. The act repeals provisions related to qualified medical providers and limited medical providers, replacing them with recommending medical providers. It moves enforcement of advertising and payment requirements from the Department of Health and Human Services to the Division of Professional Licensing.

    Took effect 1 July 2025

  • Enacted

    HB 343: Cannabis Production Amendments

    Cannabis production establishments located in industrial zones must include in their operating plan methods to reduce odor that meet local ordinance nuisance laws and identify operations generating odors and equipment or materials to mitigate emissions. The Department of Agriculture and Food must provide recommendations on objectionable odor control standards to the Medical Cannabis Governance Structure Working Group before January 1, 2026.

    Took effect 7 May 2025

Virginia

  • Enacted

    HB 75: Medical cannabis; administration to terminally ill patients, report.

    Medical care facilities must permit patients with terminal illness to use medical cannabis in accordance with the Medical Cannabis Program. Facilities must prohibit smoking or vaping, include cannabis use in medical records, require written certification, reasonably restrict storage and use, and develop written guidelines. Facilities need not provide certification or include cannabis in discharge plans.

  • Enacted

    SB 332: Medical marijuana; administration to terminally ill patients.

    Directs the Department of Health to convene a work group with specified stakeholders to develop policies for safe administration of medical marijuana to terminally ill patients, with regulations to be promulgated by January 1, 2027.

Washington

  • Enacted

    HB 2152: Permitting the medical use of cannabis by qualifying patients in specified health care facilities.

    Beginning January 1, 2027, hospitals, nursing homes, and hospice care centers must permit medical use of cannabis by qualifying patients with terminal conditions according to facility policy. Policies must prohibit smoking or vaping, require patient records documentation, secure storage, and prohibit staff from administering or retrieving cannabis.

  • Enacted

    HB 1341: Concerning the medical cannabis authorization database.

    The department must contract with an entity to create, administer, and maintain a secure medical cannabis authorization database. The liquor and cannabis board must use this database to verify excise tax exemptions under RCW 69.50.535. Cannabis retailers with medical cannabis endorsements must enter qualifying patients and designated providers into the database and issue recognition cards.

Bills that moved most recently

The 25 open medical cannabis bills with the latest action. The Cannabis Legislation Tracker follows all 427.

  • Puerto Rico RC 609: Para ordenar a la Comisión de Banca, Seguros y Comercio de la Cámara de Representantes de Puerto Rico, realizar una investigación exhaustiva sobre las operaciones de Futucare, LLC (proveedora contratada para administrar la plataforma digital del Programa de Cannabis Medicinal del Departamento de Salud) y Vank, LLC (operadora de la plataforma Vankpay, intermediaria tecnológica de pagos electrónicos entre pacientes y dispensarios), con especial énfasis en el cumplimiento de las leyes y reglamentos financieros federales y estatales que rigen las transacciones bancarias en la industria del cannabis medicinal, incluyendo la Ley de Secreto Bancario (Bank Secrecy Act, BSA), las directrices de la Red de Control de Delitos Financieros (Financial Crimes Enforcement Network, FinCEN) y las regulaciones de la Oficina del Comisionado de Instituciones Financieras (OCIF).

    What it would do: Orders the Chamber's Banking, Insurance and Commerce Commission to investigate Futucare, LLC and Vank, LLC's compliance with federal and state financial regulations governing medical cannabis transactions, including the Bank Secrecy Act, FinCEN guidelines, and OCIF regulations, with a report due within 180 days.

    In committee

  • Pennsylvania SB 120: An Act providing for cannabis; regulating the personal use and possession of cannabis; establishing the Cannabis Control Board; providing for powers and duties of the Cannabis Control Board; establishing the Cannabis Regulation Fund; providing for disproportionately impacted area, for regulation of cannabis business establishments, for enforcement and immunities, for laboratory testing, for advertising, marketing, packaging and labeling and for preparation, destruction and regulation of cannabis, edible and infused products; imposing a sales tax and excise tax on cannabis, edible and infused products; establishing the Cannabis Regulation Fund; providing for cannabis clean slate and for miscellaneous provisions; imposing penalties; consolidating provisions relating to medical use of cannabis; transferring powers and duties of the Department of Health to the Cannabis Control Board; and making repeals.

    What it would do: Establishes a Cannabis Control Board to regulate adult-use and medical cannabis in Pennsylvania. Permits individuals 21+ to possess cannabis, creates licensing for dispensaries and cultivation centers, imposes sales and excise taxes, and consolidates medical cannabis regulations under the new board.

    In committee

  • Puerto Rico PC 1502: Para enmendar el Artículo 4; enmendar el inciso (j) y añadir nuevos incisos (q), (r), (s) y (t) al Artículo 5; enmendar el Artículo 6; enmendar el Artículo 21; enmendar el Artículo 22; enmendar el Artículo 26; y añadir un nuevo Artículo 26-A a la Ley 42-2017, según enmendada, conocida como “Ley para Manejar el Estudio, Desarrollo e Investigación del Cannabis para la Innovación, Normas Aplicables y Límites” (“Ley MEDICINAL”), a los fines de separar la Junta Reglamentadora del Cannabis Medicinal del Departamento de Salud y constituirla como una entidad jurídica independiente y separada de cualquier otra agencia, departamento, dependencia, corporación pública o instrumentalidad del Gobierno de Puerto Rico, con personalidad jurídica propia; reconstituir su composición y disponer que sea presidida por un Presidente o Presidenta a tiempo completo, nombrado por el Gobernador con el consejo y consentimiento del Senado de Puerto Rico, por término fijo y removible solo por justa causa; facultar a la Junta para preparar, aprobar y someter su propio presupuesto, organizar su estructura interna y adoptar su propio reglamento de personal; crear el Fondo Especial de la Junta Reglamentadora del Cannabis Medicinal y disponer que ingresen a este los derechos y aranceles de licencias y el cincuenta por ciento (50%) de los recaudos por multas administrativas que no se destina a la Universidad de Puerto Rico; disponer que en el Presupuesto General de Gastos se consigne anualmente, con carácter recurrente, una asignación para el funcionamiento de la Junta que no será menor que la vigente al momento de la aprobación de esta Ley; establecer las disposiciones transitorias de transferencia, continuidad y nombramientos; y para otros fines relacionados.

    What it would do: Separates the Medical Cannabis Regulatory Board from the Department of Health as an independent entity with its own legal personality, headed by a full-time President appointed by the Governor with Senate consent, and creates a Special Fund financed by licensing fees and fifty percent of administrative fines.

    In committee

  • Puerto Rico PC 1281: Para enmendar los Artículos 2, 3, 5, 10, 11, 12, 13, 14, 15, 17, 21, 22, 24, y 27 de la Ley 42-2017, según enmendada, conocida como “Ley para Manejar el Estudio, Desarrollo e Investigación del Cannabis para la Innovación, Normas Aplicables y Límites (“Ley MEDICINAL”)”, con el propósito de atemperar la Ley a la realidad actual del cannabis medicinal como tratamiento paliativo, aclarar los fines perseguidos por esta Ley, la política pública del Gobierno de Puerto Rico, establecer propósitos y porcientos de asignación en relación con los fondos recaudados por multas y licencias, atemperar reglamentación y para otros fines relacionados.

    What it would do: Amends Puerto Rico's medical cannabis law to restrict use to certified terminal medical conditions or debilitating conditions directly associated with terminal conditions, allows all licensed physicians to recommend cannabis without additional licensing, and allocates 50% of fine revenues to UPR cannabis research and 50% of license revenues to catastrophic disease fund.

    In committee

  • Congress H.R. 10655: VA Medicinal Cannabis Research Act of 2026

    What it would do: Directs the VA Secretary to conduct an 18-month observational study on cannabis effects for veterans with chronic pain and PTSD, then conduct clinical trials if feasible, with annual reports to Congress over five years.

    In committee

  • Puerto Rico PS 896: Para añadir el subinciso (5) al inciso (C) y enmendar el inciso (D) del Artículo 24 de la Ley Núm. 42-2017, según enmendada, conocida como "Ley para Manejar el Estudio, Desarrollo e Investigaci6n del Cannabis para la Innovación, Normas Aplicables y Límites (Ley MEDICINAL)", a fin de aclarar prohibiciones con respecto a la utilización de cannabis medicinal para determinados empleados de transporte.

    What it would do: Adds a new subsection to Article 24 of Law 42-2017 (the Medical Cannabis Law) to clarify prohibitions on medical cannabis use for certain transportation employees.

    Passed chamber

  • Puerto Rico PS 1498: Para enmendar los artículos 5, 10 y 22 de la Ley 42-2017, según enmendada, conocida como “Ley para Manejar el Estudio, Desarrollo e Investigación del Cannabis para la Innovación, Normas Aplicables y Límites (“Ley MEDICINAL”)”, a los fines de prohibir el consumo, la venta y la distribución de cannabis medicinal, muestras de cannabis medicinal o productos de cannabis medicinal o muestras de esos productos, en presencia de menores de edad; enmendar el Artículo 10.26 de la Ley 22-2000, según enmendada, conocida como “Ley de Vehículos y Tránsito de Puerto Rico”, a los fines de prohibir el consumo de cannabis medicinal, mediante el método de vaporización en vehículos de motor cuando haya menores de edad en dicho vehículo de motor; hacer enmiendas técnicas; y para otros fines relacionados.

    What it would do: Prohibits consumption, sale, and distribution of medical cannabis in the presence of minors, and prohibits vaporization of medical cannabis in motor vehicles when minors are present. Establishes fines up to $100,000 and requires public awareness campaigns.

    In committee

  • Ohio HB 611: Issue medical marijuana processor cultivation, dispensary license

    What it would do: Allows the division of cannabis control to issue paired cultivator and dispensary licenses to licensed medical marijuana processors meeting specified requirements, including not transferring the processor license after December 2024 and having no common ownership with licensed cultivators.

    Passed chamber

  • Pennsylvania SB 1035: An Act amending the act of April 17, 2016 (P.L.84, No.16), known as the Medical Marijuana Act, providing for compassionate access to medical marijuana.

    What it would do: Amends the Medical Marijuana Act to permit terminally ill patients with a prognosis of one year or less to use medical marijuana in health care facilities, prohibiting smoking or vaping methods and requiring storage in locked containers while allowing facilities to suspend compliance if federal agencies take enforcement action.

    Passed committee

  • Pennsylvania SB 49: An Act establishing the Cannabis Control Board; providing for powers and duties of the Cannabis Control Board; establishing the Cannabis Regulation Fund; providing for permits and for dispensing cannabis to patients and caregivers; and making repeals.

    What it would do: Establishes an independent Cannabis Control Board to regulate cannabis and hemp-derived cannabinoid products in Pennsylvania, creates warehousing/distribution and third-party transporter permits, and requires dispensaries to maintain physician consultation and video surveillance.

    Floor vote

  • Puerto Rico RS 319: Para ordenar a la Comisión de Salud del Senado de Puerto Rico realizar una investigación exhaustiva sobre el efecto e impacto de la Ley Núm. 42-2017, conocida como la “Ley para Manejar el Estudio, Desarrollo e Investigación del Cannabis para la Innovación, Normas Aplicables y Límites” (“Ley MEDICINAL”), evaluando el cumplimiento de la Junta Reglamentadora del Cannabis Medicinal con los deberes que le impone la ley, así como la transparencia, efectividad y resultados del sistema de cannabis medicinal en Puerto Rico en sus aspectos administrativos, regulatorios, científicos y socioeconómicos, incluyendo su impacto en la creación de empleos y en la salud y calidad de vida de los pacientes, y para otros fines relacionados.

    Passed chamber

  • Pennsylvania HB 2694: An Act amending the act of April 17, 2016 (P.L.84, No.16), known as the Medical Marijuana Act, in preliminary provisions, further providing for definitions; in medical marijuana organizations, providing for additional dispensary permits authorized; and, in administration, providing for available licenses.

    What it would do: Amends the Medical Marijuana Act to define disadvantaged business, diverse business, and small business; authorizes the Department of Health to issue one additional dispensary permit per region to these business types; and requires the department to publish surrendered or revoked licenses by December 5 annually and accept applications for them by January 15 from these business types.

    In committee

  • District of Columbia B 26-0259: Medical Cannabis Retailer Craft Preparation Endorsement Act of 2025

    What it would do: Creates a craft preparation endorsement for medical cannabis retailers allowing them to prepare edibles, topicals, and prerolls from purchased cannabis products, with limits on floor space, storage amounts, and sales restricted to qualifying patients and caregivers.

    In committee

  • District of Columbia B 26-0346: Medical Cannabis Conditional Licensure Extension Amendment Act of 2025

    What it would do: Amends the Legalization of Marijuana for Medical Treatment Initiative of 1999 to extend conditional licenses for medical cannabis cultivation centers, retailers, internet retailers, manufacturers, couriers, and testing laboratories from 2 years to 3 years, with automatic conversion for existing licenses at no additional cost.

    In committee

  • District of Columbia B 26-0522: Medical Cannabis Process Improvement Amendment Act of 2025

    What it would do: Amends DC's medical cannabis licensing law to define preschools as child development facilities, add child development facilities to the 300-foot location restriction, permit Advisory Neighborhood Commissions to protest internet retailer licenses, and expand protest grounds to include effects on peace, order, quiet, and proximity to children.

    In committee

  • District of Columbia B 26-0654: Medical Cannabis Beverage Product Amendment Act of 2026

    What it would do: Establishes a medical cannabis beverage production endorsement for alcohol manufacturers to produce non-alcoholic cannabis beverages, creates a medical cannabinoids import endorsement for importing non-intoxicating cannabinoids, permits couriers to deliver cannabis between manufacturers and endorsement holders, and clarifies the 6% tax rate applies to medical cannabis and products.

    In committee

  • Georgia HR 24: Medical Marijuana Therapeutics; recognize

    What it would do: Recognizes and commends Medical Marijuana Therapeutics, a Georgia medical cannabis practice, for its patient-centered approach to cannabis-focused medical care and contributions to Georgia's Medical Cannabis Program.

    Passed chamber

  • Massachusetts H 176: An Act further defining eligibility for medical use marijuana

    What it would do: Expands the definition of debilitating medical condition to include opioid use disorder and allows healthcare professionals to determine other qualifying conditions in writing. Adds veterans receiving care at federal Veterans Administration facilities as qualifying patients if they provide VA documentation of a debilitating medical condition.

    Passed committee

  • Pennsylvania HB 2254: An Act amending the act of April 17, 2016 (P.L.84, No.16), known as the Medical Marijuana Act, providing for compassionate access to medical marijuana; and imposing a penalty.

    What it would do: Amends the Medical Marijuana Act to permit terminally ill patients to use medical marijuana in health care facilities, long-term care nursing facilities, assisted living residences, and personal care homes if conditions are met, and provides liability protection for facilities and employees acting in good faith.

    Passed chamber

  • New York S 3105: Relates to reciprocity agreements with other states for medical cannabis programs

    What it would do: Allows non-residents authorized for medical cannabis in their home state to possess and use cannabis in New York if they provide documentation and comply with New York's possession and production limits. Authorizes the board to enter reciprocity agreements with other states and promulgate regulations for pre-roll products.

    Passed chamber

  • New Jersey S 4297: Revises certain restrictions concerning hemp, intoxicating hemp beverages, and medical cannabis.

    What it would do: Extends hemp producer deadlines to November 13, 2026, revises intoxicating hemp beverage limits to 5-10 mg THC per serving and specifies container sizes, allows ABC bars to sell such beverages, and permits medical cannabis dispensaries to co-locate Class 5 adult use retailers without additional municipal review.

    Passed committee

  • New Hampshire SB 400: relative to duties and reporting requirements of the therapeutic cannabis medical oversight board.

    What it would do: Requires the therapeutic cannabis medical oversight board to biennially review medical and scientific evidence for currently approved and additional qualifying conditions, and mandates the board's annual report include citations to such evidence.

    Passed chamber

  • Missouri HB 1898: Requires publicly funded state colleges and universities to allow medical marijuana use on campus

    What it would do: Requires each public institution of higher education supported by state funds to allow students to use marijuana or marijuana-infused products for medical use as authorized by state law on campus. Authorizes the department of higher education and workforce development to promulgate rules for administration.

    In committee

  • Missouri SB 904: Creates provisions relating to cannabis

    What it would do: Repeals and replaces cannabis-related definitions in Missouri law. Creates provisions protecting medical marijuana patient privacy from federal disclosure, allowing dispensaries to not retain consumer records, and regulating hemp-derived cannabinoid products as marijuana subject to licensing requirements.

    Passed committee

  • Oklahoma HJR 1101: Joint Resolution; Oklahoma Medical Marijuana Authority; approving certain proposed permanent rules; directing distribution.

    What it would do: Approves permanent administrative rules submitted by the Oklahoma Medical Marijuana Authority on or before February 1, 2026, specifically rules OAC 442:1-1-1, 442:1-1-6 through 442:1-1-13, 442:1-1-16 through 442:1-1-20. Directs the Oklahoma Secretary of State to distribute copies to the Governor and The Oklahoma Register.

    Passed chamber

Questions

Which states have medical cannabis laws?

States that enacted medical cannabis laws in 2025 and 2026: Oklahoma (11), Utah (6), District of Columbia (5), Colorado (3), Maine (3), North Dakota (3), Tennessee (3), Arkansas (2), Georgia (2), Hawaii (2), Louisiana (2), Minnesota (2), Mississippi (2), Nebraska (2), New Jersey (2), Virginia (2), Washington (2), Arizona (1), Delaware (1), Florida (1), Iowa (1), Maryland (1), Massachusetts (1), Missouri (1), Montana (1), Nevada (1), New York (1), Ohio (1), Oregon (1), South Dakota (1) and Texas (1). Laws enacted before 2025 are not listed here.

Which states have the most medical cannabis bills?

Oklahoma (51), New Jersey (27), Florida (26), West Virginia (21) and Mississippi (20). In all, 427 bills in 50 jurisdictions, the latest action on 23 October 2026.

What do medical cannabis bills cover?

Medical cannabis programs, qualifying conditions, patient protections, caregivers and medical dispensaries. Each enacted law above has a line on what it requires.

Is this legal advice?

No. Which bills count as medical cannabis bills, and the line on what each law requires or each bill would do, are drafted by software and not reviewed by an attorney. Every bill links to the legislature’s own record: read the text before relying on it. The list covers bills from the 2025 and 2026 sessions.

Follow medical cannabis bills in every state

The Cannabis Legislation Tracker sends the bills that moved and a monthly report you can forward to a client.